Summit Therapeutics Inc.

SMMT
As of the close on Sep 25, 2026
Price
$15.61
Market cap
—
The company filed earlier annual reports as a foreign issuer, and its US listing is not confirmed to be one ordinary share
P/E (diluted TTM)
—
The company filed earlier annual reports as a foreign issuer, and its US listing is not confirmed to be one ordinary share
EPS (TTM)
—
The company filed earlier annual reports as a foreign issuer, and its US listing is not confirmed to be one ordinary share
Dividend yield
—
The company filed earlier annual reports as a foreign issuer, and its US listing is not confirmed to be one ordinary share

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How Summit Therapeutics Inc. Makes Money

Follow each dollar of revenue through to what shareholders keep.

From revenue to net income

Pick a year or quarter. Each band's width is its dollar amount.

Source: Summit Therapeutics Inc. — 10-K filed Feb 24, 2025

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 9 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 12, 2026. The latest institutional report shown is dated Jun 30, 2025; other ownership filings may exist.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Reported 13F positions

Each row shows what a filer reported for one date, not a current position. The link opens that filing.

Filer Report date Shares Value Filing
TWIN PEAKS WEALTH ADVISORS, LLC 2025-06-30 1 $26 SEC filing
Parallel Advisors, LLC 2025-06-30 2,042 $43.5K SEC filing
SIERRA OCEAN, LLC 2025-06-30 38 $809 SEC filing
Bay Harbor Wealth Management, LLC 2025-06-30 5 $106 SEC filing
Fortitude Family Office, LLC 2025-06-30 15 $319 SEC filing
Farther Finance Advisors, LLC 2025-06-30 560 $11.9K SEC filing
Rise Advisors, LLC 2025-06-30 28 $596 SEC filing
Rosenberg Matthew Hamilton 2025-06-30 501 $10.7K SEC filing
AdvisorNet Financial, Inc 2025-06-30 22 $468 SEC filing
Park Place Capital Corp 2025-06-30 62 $1.31K SEC filing
EverSource Wealth Advisors, LLC 2025-06-30 370 $7.87K SEC filing
Roxbury Financial LLC 2025-06-30 187 $3.98K SEC filing
EverSource Wealth Advisors, LLC 2025-03-31 453 Not shown SEC filing
Parallel Advisors, LLC 2025-03-31 19 Not shown SEC filing
Rise Advisors, LLC 2025-03-31 55 Not shown SEC filing
ROTHSCHILD INVESTMENT LLC 2025-03-31 195 Not shown SEC filing
AdvisorNet Financial, Inc 2025-03-31 22 Not shown SEC filing
Guardian Wealth Management, Inc. 2025-03-31 70 Not shown SEC filing
Lindbrook Capital, LLC 2025-03-31 843 Not shown SEC filing
Bay Harbor Wealth Management, LLC 2025-03-31 4 Not shown SEC filing
  • Each value is checked against Summit Therapeutics Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
  • Value not shown for 8 rows: no share price from within three months of their report dates is on file, so they could not be checked.

Filer report history

Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.

  • EverSource Wealth Advisors, LLC: 453 shares reported 2025-03-31; 370 shares reported 2025-06-30.
  • AdvisorNet Financial, Inc: 22 shares reported 2025-03-31; 22 shares reported 2025-06-30.
  • Rise Advisors, LLC: 55 shares reported 2025-03-31; 28 shares reported 2025-06-30.
  • Farther Finance Advisors, LLC: 654 shares reported 2025-03-31; 560 shares reported 2025-06-30.
  • Bay Harbor Wealth Management, LLC: 4 shares reported 2025-03-31; 5 shares reported 2025-06-30.
  • Parallel Advisors, LLC: 19 shares reported 2025-03-31; 2,042 shares reported 2025-06-30.
  • EverSource Wealth Advisors, LLC: 418 shares reported 2024-12-31; 453 shares reported 2025-03-31.
  • Farther Finance Advisors, LLC: 12 shares reported 2024-12-31; 654 shares reported 2025-03-31.
  • Global Financial Private Client, LLC: 1 share reported 2024-12-31; 5 shares reported 2025-03-31.
  • Lindbrook Capital, LLC: 755 shares reported 2024-12-31; 843 shares reported 2025-03-31.
  • ROTHSCHILD INVESTMENT LLC: 120 shares reported 2024-12-31; 195 shares reported 2025-03-31.
  • Lindbrook Capital, LLC: 755 shares reported 2024-09-30; 755 shares reported 2024-12-31.

Showing the 12 most recent filer reports.

9 filers have only one report here.

Independent insiders buying near the same time

  • 2026-06-12–2026-06-12: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
  • 2026-06-04–2026-06-04: 4 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
  • 2025-10-21–2025-10-21: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
  • 2025-09-10–2025-09-11: 4 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
  • 2024-03-26–2024-03-27: 5 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing )
  • 2023-12-12–2023-12-13: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
  • 2021-05-12–2021-05-12: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )

Purchases & sales (open market or private)

SecurityCodePriceFiling
2026-06-12Zanganeh Mahkam · Co-Chief Executive OfficerCommon StockP — Open market or private purchase+3,810,00013.12SEC filing
2026-06-12DUGGAN ROBERT W · Co-Chief Executive OfficerCommon StockP — Open market or private purchase+3,810,00013.12SEC filing
2026-06-04Soni Manmeet Singh · COO and CFOCommon StockP — Open market or private purchase+25,00014.46SEC filing
2026-06-04Soni Manmeet Singh · COO and CFOCommon StockP — Open market or private purchase+25,00014.43SEC filing
2026-06-04Zanganeh Mahkam · Co-Chief Executive OfficerCommon StockP — Open market or private purchase+100,00014.60SEC filing
2026-06-04DUGGAN ROBERT W · Co-Chief Executive OfficerCommon StockP — Open market or private purchase+100,00014.60SEC filing
2025-10-21Xia Yu · DirectorCommon StockP — Open market or private purchase+533,61718.74SEC filing
2025-10-21Zanganeh Mahkam · Co-Chief Executive OfficerCommon StockP — Open market or private purchase+26,68018.74SEC filing

Showing 8 of 15 rows

Grants, exercises, tax & gifts

SecurityCodeFiling
2026-01-08Anand Bhaskar · Chief Accounting OfficerStock Option (right to buy)A — Grant, award, or other acquisition+30,000SEC filing
2026-01-02Clark Kenneth A · DirectorStock Option (right to buy)A — Grant, award, or other acquisition+35,000SEC filing
2026-01-02Booth Robert F. · DirectorStock Option (right to buy)A — Grant, award, or other acquisition+35,000SEC filing
2026-01-02Clark Kenneth A · DirectorStock Option (right to buy)A — Grant, award, or other acquisition+17,796SEC filing
2026-01-02Cesano Alessandra · DirectorStock Option (right to buy)A — Grant, award, or other acquisition+35,000SEC filing
2026-01-02Xia Yu · DirectorStock Option (right to buy)A — Grant, award, or other acquisition+35,000SEC filing
2026-01-02DUGGAN ROBERT W · Co-Chief Executive OfficerStock Option (right to buy)A — Grant, award, or other acquisition+11,232SEC filing
2026-01-02Booth Robert F. · DirectorStock Option (right to buy)A — Grant, award, or other acquisition+7,180SEC filing

Showing 8 of 20 rows

Other activity

SecurityCodeFiling
2022-12-06Zanganeh Mahkam · Co-CEO & PresidentCommon StockJ — Other acquisition or disposition+373,857SEC filing
2022-12-06DUGGAN ROBERT W · Chief Executive OfficerCommon StockJ — Other acquisition or disposition+9,346,434SEC filing
2022-05-23DUGGAN ROBERT W · Chief Executive OfficerCommon StockJ — Other acquisition or disposition+21,135SEC filing
2021-02-19Donaldson Michael Paul · Chief Financial OfficerStock Option (right to buy)D — Disposition to the issuer−5,110SEC filing

Showing 4 of 4 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.